1. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Issue 7 (July 2020) Authors: Heinrich, Michael C; Jones, Robin L; von Mehren, Margaret; Schöffski, Patrick; Serrano, César; Kang, Yoon-Koo; Cassier, Philippe A; Mir, Olivier; Eskens, Ferry; Tap, William D; Rutkowski, Piotr; Chawla, Sant P; Trent, Jonathan; Tugnait, Meera; Evans, Erica K; Lauz, Tamieka; Zhou, Teresa; Roche, M... Journal: Lancet oncology Issue: Volume 21:Issue 7(2020) Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy. Issue 10 (3rd October 2021) Authors: Henriques-Abreu, Miguel; Serrano, César Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 10(2021) Page Start: 1081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. (March 2021) Authors: Jones, Robin L.; Serrano, César; von Mehren, Margaret; George, Suzanne; Heinrich, Michael C.; Kang, Yoon-Koo; Schöffski, Patrick; Cassier, Philippe A.; Mir, Olivier; Chawla, Sant P.; Eskens, Ferry A.L.M.; Rutkowski, Piotr; Tap, William D.; Zhou, Teresa; Roche, Maria; Bauer, Sebastian Journal: European journal of cancer Issue: Volume 145(2021) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours. Issue 3 (27th November 2012) Authors: Serrano, César; Simonetti, Sara; Hernández‐Losa, Javier; Valverde, Claudia; Carrato, Cristina; Bagué, Silvia; Orellana, Ruth; Somoza, Rosa; Moliné, Teresa; Carles, Joan; Huguet, Pere; Romagosa, Cleofé; Ramón y Cajal, Santiago Journal: Histopathology Issue: Volume 62:Issue 3(2013) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BWR Mark III containment analyses using a GOTHIC 8.0 3D model. (November 2015) Authors: Jimenez, Gonzalo; Serrano, César; Lopez-Alonso, Emma; Molina, M del Carmen; Calvo, Daniel; García, Javier; Queral, César; Zuriaga, J. Vicente; González, Montserrat Journal: Annals of nuclear energy Issue: Volume 85(2015:Nov.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BWR Mark III containment analyses using a GOTHIC 8.0 3D model. (November 2015) Authors: Jimenez, Gonzalo; Serrano, César; Lopez-Alonso, Emma; Molina, M del Carmen; Calvo, Daniel; García, Javier; Queral, César; Zuriaga, J. Vicente; González, Montserrat Journal: Annals of nuclear energy Issue: Volume 85(2015:Nov.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021) Authors: Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz-Soto... Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: e2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021) Authors: Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz‐Soto... Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: e2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors. (February 2019) Authors: Ravegnini, Gloria; Sammarini, Giulia; Serrano, César; Nannini, Margherita; Pantaleo, Maria A.; Hrelia, Patrizia; Angelini, Sabrina Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib. (20th August 2018) Authors: Serrano, César; García‐del‐Muro, Xavier; Valverde, Claudia; Sebio, Ana; Durán, José; Manzano, Aránzazu; Pajares, Isabel; Hindi, Nadia; Landolfi, Stefania; Jiménez, Laura; Rubió‐Casadevall, Jordi; Estival, Anna; Lavernia, Javier; Safont, María José; Pericay, Carles; Díaz‐Beveridge, Roberto; Martín... Journal: Oncologist Issue: Volume 24:Number 5(2019) Page Start: 680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗